Across TCGA pan-cancer cohorts, RNU6ATAC24P RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated RNU6ATAC24P data layer.
The strongest signal is observed in colon adenocarcinoma (COAD), where higher RNU6ATAC24P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6ATAC24P expression acts as an unfavorable survival marker, although some lineages such as BRCA and READ show a favorable association.
COAD, BRCA, and READ are the cancer types where RNU6ATAC24P RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.